Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting JR Nebeker, P Barach, MH Samore Annals of internal medicine 140 (10), 795-801, 2004 | 994 | 2004 |
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project JR Nebeker, R Virmani, CL Bennett, JM Hoffman, MH Samore, J Alvarez, ... Journal of the American College of Cardiology 47 (1), 175-181, 2006 | 835 | 2006 |
High rates of adverse drug events in a highly computerized hospital JR Nebeker, JM Hoffman, CR Weir, CL Bennett, JF Hurdle Archives of internal medicine 165 (10), 1111-1116, 2005 | 527 | 2005 |
Risk factors for adverse drug events: a 10-year analysis RS Evans, JF Lloyd, GJ Stoddard, JR Nebeker, MH Samore Annals of Pharmacotherapy 39 (7-8), 1161-1168, 2005 | 239 | 2005 |
Direct text entry in electronic progress notes CR Weir, JF Hurdle, MA Felgar, JM Hoffman, B Roth, JR Nebeker Methods of information in medicine 42 (01), 61-67, 2003 | 176 | 2003 |
The research on adverse drug events and reports (RADAR) project CL Bennett, JR Nebeker, EA Lyons, MH Samore, MD Feldman, JM McKoy, ... Jama 293 (17), 2131-2140, 2005 | 163 | 2005 |
A cognitive task analysis of information management strategies in a computerized provider order entry environment CR Weir, JJR Nebeker, BL Hicken, R Campo, F Drews, B LeBar Journal of the American Medical Informatics Association 14 (1), 65-75, 2007 | 148 | 2007 |
Medication reconciliation: barriers and facilitators from the perspectives of resident physicians and pharmacists KS Boockvar, SL Santos, A Kushniruk, C Johnson, JR Nebeker Journal of Hospital Medicine 6 (6), 329-337, 2011 | 124 | 2011 |
Prescribing discrepancies likely to cause adverse drug events after patient transfer KS Boockvar, S Liu, N Goldstein, J Nebeker, A Siu, T Fried BMJ Quality & Safety 18 (1), 32-36, 2009 | 116 | 2009 |
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? EA Richey, EA Lyons, JR Nebeker, V Shankaran, JM McKoy, TH Luu, ... Journal of clinical oncology 27 (26), 4398, 2009 | 109 | 2009 |
pSCANNER: Patient-centered scalable national network for effectiveness research L Ohno-Machado, Z Agha, DS Bell, L Dahm, ME Day, JN Doctor, ... Journal of the American Medical Informatics Association 21 (4), 621-626, 2014 | 93 | 2014 |
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports … LA Ladewski, SM Belknap, JR Nebeker, O Sartor, EA Lyons, TC Kuzel, ... Journal of clinical oncology 21 (20), 3859-3866, 2003 | 89 | 2003 |
Histologic features of human orbicularis oculi treated with botulinum A toxin CP Harris, K Alderson, J Nebeker, JB Holds, RL Anderson Archives of ophthalmology 109 (3), 393-395, 1991 | 87 | 1991 |
Effect of admission medication reconciliation on adverse drug events from admission medication changes KS Boockvar, S Blum, A Kugler, E Livote, KA Mergenhagen, JR Nebeker, ... Archives of internal medicine 171 (9), 860-861, 2011 | 86 | 2011 |
Pharmacist-versus physician-initiated admission medication reconciliation: impact on adverse drug events KA Mergenhagen, SS Blum, A Kugler, EE Livote, JR Nebeker, MC Ott, ... The American journal of geriatric pharmacotherapy 10 (4), 242-250, 2012 | 84 | 2012 |
Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review S Phansalkar, JM Hoffman, JR Nebeker, JF Hurdle American journal of health-system pharmacy 64 (8), 842-849, 2007 | 83 | 2007 |
Synonym, topic model and predicate-based query expansion for retrieving clinical documents QT Zeng, D Redd, T Rindflesch, J Nebeker AMIA Annual Symposium Proceedings 2012, 1050, 2012 | 71 | 2012 |
Using ICD-9-CM codes in hospital claims data to detect adverse events in patient safety surveillance P Hougland, J Nebeker, S Pickard, M Van Tuinen, C Masheter, S Elder, ... Advances in patient safety: new directions and alternative approaches (Vol …, 2008 | 67 | 2008 |
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and … CL Bennett, JR Nebeker, PR Yarnold, CC Tigue, DA Dorr, JM McKoy, ... Archives of internal medicine 167 (10), 1041-1049, 2007 | 64 | 2007 |
Evaluation of the impact of a CPOE System on Nurse-physician communication H Pirnejad, Z Niazkhani, H van der Sijs, M Berg, R Bal Methods of information in medicine 48 (04), 350-360, 2009 | 62 | 2009 |